Michelle Moser, RPh, FACA, FACVP – Fillers – 2022 Conference (LDN; low dose naltrexone)
Michelle Moser, RPh, FACA, FACVP – Fillers – 2022 Conference (LDN; low dose naltrexone)
Neel Mehta, MD – An Alternative to Opioids – 2022 Conference (LDN; low dose naltrexone)
Neel Mehta, MD – An Alternative to Opioids – 2022 Conference (LDN; low dose naltrexone)
Michael McCaughley, MPharm IP – LDN and Long COVID – 2022 Conference (LDN; low dose naltrexone)
Michael McCaughley, MPharm IP – LDN and Long COVID – 2022 Conference (LDN; low dose naltrexone)
Lauren Mathewson, ND – LDN Case Studies – 2022 Conference (LDN; low dose naltrexone)
Lauren Mathewson, ND – LDN Case Studies – 2022 Conference (LDN; low dose naltrexone)
Elizabeth Livengood, ND – Peptides – 2022 Conference (LDN; low dose naltrexone)
Elizabeth Livengood, ND – Peptides – 2022 Conference (LDN; low dose naltrexone)
Christine Lee, PharmD – Migraines – 2022 Conference (LDN; low dose naltrexone)
Christine Lee, PharmD – Migraines – 2022 Conference (LDN; low dose naltrexone)
Kent Holtorf, MD – Mold and CIRS – 2022 Conference (LDN; low dose naltrexone)
Kent Holtorf, MD – Mold and CIRS – 2022 Conference (LDN; low dose naltrexone)
J Stephen Dickson, MRPharmS, BSC (Hons) – Uses of LDN, History and Pharmacology – 2022 Conference (LDN; low dose naltrexone)
J Stephen Dickson, MRPharmS, BSC (Hons) – Uses of LDN, History and Pharmacology – 2022 Conference (LDN; low dose naltrexone)
Kristen Cardamone, DO, FABPMR – LDN in Pain – 2022 Conference (LDN; low dose naltrexone)
Kristen Cardamone, DO, FABPMR – LDN in Pain – 2022 Conference (LDN; low dose naltrexone)
Phil Boyle, MRCGP, MICGP – PMS and PMDD – LDN Side Effects – 2022 Conference (LDN; low dose naltrexone)
Phil Boyle, MRCGP, MICGP – PMS and PMDD – LDN Side Effects – 2022 Conference (LDN; low dose naltrexone)